<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>isfcppharmaspire</PublisherName>
      <JournalTitle>Pharmaspire</JournalTitle>
      <PISSN>C</PISSN>
      <EISSN>o</EISSN>
      <Volume-Issue>Volume 15, Issue 02, 2023</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>April- June</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2023</Year>
        <Month>09</Month>
        <Day>7</Day>
      </PubDate>
      <ArticleType>Pharmacology</ArticleType>
      <ArticleTitle>Advancing neuroprotection in traumatic brain injury: Maximizing the potential of the nuclear factor erythroid 2-related factor 2/nuclear factor kappa B pathway through insights from animal models</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>74</FirstPage>
      <LastPage>79</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Mayank</FirstName>
          <LastName>Kumar</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Shamsher</FirstName>
          <LastName>Singh</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI>10.56933/Pharmaspire.2023.15113</DOI>
      <Abstract>Traumatic brain injury (TBI) is a primary public health concern that can result in significant long-term disability and mortality. Neuroprotection strategies that can mitigate the effects of TBI are urgently needed. The nuclear factor erythroid 2-related factor 2 (Nrf-2)/nuclear factor kappa B (NF-__ampersandsignkappa;B) pathway has emerged as a promising TBI neuroprotection target because it regulates inflammation, oxidative stress, and mitochondrial dysfunction. This review summarizes the current preclinical evidence supporting the role of the Nrf-2/NF-__ampersandsignkappa;B pathway in TBI and the mechanisms underlying its regulation. Pharmacological and genetic approaches have been used to modulate the pathway in animal models of TBI, resulting in improved functional, histological, and molecular outcomes. The molecular mechanisms underlying the Nrf-2/NF-__ampersandsignkappa;B pathway in TBI involve regulating inflammation, oxidative stress, and mitochondrial dysfunction. The future studies should focus on identifying safe and effective agents for modulating this pathway, optimizing dosing regimens, and exploring combination therapies targeting multiple TBI pathways. While preclinical studies have shown promising results, further research is needed to determine the safety and efficacy of modulating the Nrf-2/NF-__ampersandsignkappa;B pathway in human TBI patients. Overall, the Nrf-2/NF-__ampersandsignkappa;B pathway represents a promising target for neuroprotection in TBI, and further research is needed to translate these preclinical findings into effective treatments for human patients.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Genetic approaches, Inflammation, Mitochondrial dysfunction, Molecular mechanisms, Neuroprotection, Nuclear factor erythroid 2-related factor 2/Nuclear factor kappa B pathway, Oxidative stress, Pharmacological approaches, Preclinical evidence, Traumatic brain injury</Keywords>
      <URLs>
        <Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=14810&amp;title=Advancing neuroprotection in traumatic brain injury: Maximizing the potential of the nuclear factor erythroid 2-related factor 2/nuclear factor kappa B pathway through insights from animal models</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: A brief overview. J Head Trauma Rehabil 2006;21:375-8.&#13;
2. Angeloni C, Prata C, Sega FV, Piperno R, Hrelia S. Traumatic brain injury and NADPH oxidase: A deep relationship. Oxid Med Cell Longev 2015;2015:370312.&#13;
3. Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD, Oddo M, et al. Neuroprotection in acute brain injury: An up-to-date review. Crit Care 2015;19:186.&#13;
4. Kaur U, Banerjee P, Bir A, Sinha M, Biswas A, Chakrabarti S. Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer’s disease: The NF-and;kappa;B connection. Curr Topics Med Chem 2015;15:446-57.&#13;
5. Ikram M, Park HY, Ali T, Kim MO. Melatonin as a potential regulator of oxidative stress, and neuroinflammation: Mechanisms and implications for the management of brain injury-induced neurodegeneration. J Inflamm Res 2021;14:6251-4.&#13;
6. Zhao H, Eguchi S, Alam A, Ma D. The role of nuclear factor-erythroid 2 related factor 2 (Nrf-2) in the protection against lung injury. Am J Physiol Lung Cell Mol Physiol 2017;312:L155-62.&#13;
7. Rushworth SA, Ogborne RM, Charalambos CA, O’Connell MA. Role of protein kinase C and;delta; in curcumininduced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 2006;341:1007-16.&#13;
8. Karin M, editor The Iand;kappa;B Kinase (IKK) Complex as a Critical Regulator of Immune Responses. In: International Congress Series. Netherlands: Elsevier; 2005.&#13;
9. Cerpa-Cruz S, Gonzand;aacute;lez-Dand;iacute;az V, Martand;iacute;nez-Bonilla G,&#13;
Gutiand;eacute;rrez-Ureand;ntilde;a S, Rodrand;iacute;guez-Cortand;eacute;s E, Garcia- Espinosa L. Non-alcoholic fatty steatohepatitis an inflammatory disorder beyond the liver. J Clin Cell Immunol 2013;4:159.&#13;
10. Khan A, Ikram M, Muhammad T, Park J, Kim MO. Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 in vivo and in vitro. J Clin Med 2019;8:680.&#13;
11. Shal B, Khan A, Khan AU, Ullah R, Naveed M, Ali G, et al. Coagulansin-A improves spatial memory in 5xFAD Tg mice by targeting Nrf-2/NF-and;kappa;B and Bcl-2 pathway. Int Immunopharmacol 2022;109:108860.&#13;
12. Lee S, Kim J, Seo SG, Choi BR, Han JS, Lee KW, et al. Sulforaphane alleviates scopolamine-induced memory impairment in mice. Pharmacol Res 2014;85:23-32.&#13;
13. Thiruvengadam M, Venkidasamy B, Subramanian U, Samynathan R, Ali Shariati M, Rebezov M, et al. Bioactive compounds in oxidative stress-mediated diseases: Targeting the NRF2/ARE signaling pathway and epigenetic regulation. Antioxidants (Basel) 2021;10:1859.&#13;
14. Biswas M, Das A, Basu S. Flavonoids: The innocuous agents offering protection against Alzheimer’s disease through modulation of proinflammatory and apoptotic pathways. Curr Top Med Chem 2022;22:769-89.&#13;
15. Cordaro M, D’Amico R, Fusco R, Peritore AF, Genovese T, Interdonato L, et al. Discovering the effects of fisetin on NF-and;kappa;B/NLRP-3/NRF-2 molecular pathways in a mouse model of vascular dementia induced by repeated bilateral carotid occlusion. Biomedicines 2022;10:1448.&#13;
16. Goodfellow MJ, Borcar A, Proctor JL, Greco T, Rosenthal RE, Fiskum G. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration. Exp Neurol 2020;328:113247.&#13;
17. Gatsinzi T, Iverfeldt K. Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-and;kappa;B inhibitors is dependent on reactive oxygen species (ROS). J Neurooncol 2011;104:459-72.&#13;
18. Xu B, Qin Y, Li D, Cai N, Wu J, Jiang L, et al. Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway. Redox&#13;
Biol 2020;28:101342.&#13;
19. Zhang JY, Lee JH, Gu X, Wei ZZ, Harris MJ, Yu SP, et al. Intranasally delivered Wnt3a improves functional recovery after traumatic brain injury by modulating autophagic, apoptotic, and regenerative pathways in the mouse brain. J Neurotrauma 2018;35:802-13.&#13;
20. Fujimoto ST, Longhi L, Saatman KE, McIntosh TK. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 2004;28:365-78.&#13;
21. Ocak PE, Ocak U, Sherchan P, Gamdzyk M, Tang J, brain barrier dysfunction via Cav-1/Keap-1/Nrf-2/HO-1 pathway in a rat model of surgical brain injury. Exp Neurol 2020;326:113203.&#13;
22. Bibi T, Khan A, Khan AU, Shal B, Ali H, Seo EK, et al. Magnolol prevented brain injury through the modulation of Nrf2-dependent oxidative stress and apoptosis in PLPinduced mouse model of multiple sclerosis. Naunyn Schmiedebergs Arch Pharmacol 2022;395:717-33.&#13;
23. Aslan A, Gok O, Beyaz S, Uslu H, Erman F, Erman O, et al. Ellagic acid inhibits proinflammatory intermediary manufacture by suppressing NF-and;kappa;B/Akt, VEGF and activating Nrf-2/Caspase-3 signaling pathways in rat testicular damage: A new way for testicular damage cure and in silico approach. Toxicol Mech Methods 2022;32:463-76.&#13;
24. Bajpai VK, Alam MB, Quan KT, Kwon KR, Ju MK, Choi HJ, et al. Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38. Sci Rep 2017;7:46035.&#13;
25. Cho W, Nam JW, Kang HJ, Windono T, Seo EK, Lee KT. Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-and;kappa;B pathway in LPS-stimulated murine macrophages. Int Immunopharmacol 2009;9:1049-57.&#13;
26. Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother 2015;74:101-10.&#13;
27. Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 2015;72:355-62.&#13;
28. Wang JY, Wen LL, Huang YN, Chen YT, Ku MC. Dual effects of antioxidants in neurodegeneration: Direct neuroprotection against oxidative stress and indirect protection via suppression of gliamediated inflammation. Curr Pharm Des 2006;12:3521-33.&#13;
29. Aitken RJ. Reactive oxygen species as mediators of sperm capacitation and pathological damage. Mol Reprod Dev 2017;84:1039-52.&#13;
30. Jin T, Leng B. Cynaropicrin averts the oxidative stress and neuroinflammation in ischemic/reperfusion injury through the modulation of NF-kB. Appl Biochem Biotechnol 2022;15:1-15.&#13;
31. Oluranti OI, Alabi BA, Michael OS, Ojo AO, Fatokun BP. Rutin prevents cardiac oxidative stress and inflammation induced by bisphenol A and dibutyl phthalate exposure via NRF-2/NF-and;kappa;B pathway. Life Sci 2021;284:119878.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>